Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer

Overview of attention for article published in Clinical Cancer Research, November 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 10 news outlets

twitter: 34 X users

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 17 news stories from 10 outlets.

Circulating tumor DNA levels predict outcomes for gastroesophageal cancer treated with immunotherapy

MedicalXpress, 19 Mar 2024

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how…

Tumor DNA Levels Forecast Immunotherapy Success in Cancer

Mirage News, 19 Mar 2024

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how…

Circulating tumor DNA levels predict treatment outcomes for patients with gastroesophageal cancer treated with a novel immunotherapy combination

EurekAlert!, 19 Mar 2024

image: Liquid biopsies. view more Credit: DALL-E x Fritz Kahn, Valsamo Anagnostou Monitoring levels of DNA shed by tumors and…

Circulating Tumor DNA Levels Predict Treatment Outcomes for Patients with Gastroesophageal Cancer Treated with a Novel Immunotherapy Combination

Sciencenewsnet.in, 19 Mar 2024

Post Views: 1 FOR IMMEDIATE RELEASE Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 13 additional news stories.